Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| cbdMD, Inc.YCBD · Entity 8230 | Director | March 11, 2022 | April 19, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
cbdMD, Inc.
Report date March 11, 2022 · Filed April 19, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 310,000 |
Reported balance
After 2022-03-11 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-11 · Grant · Acquired 5,000 · Balance 310,000 F1: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The restricted stock units vest quarterly in equal increments on June 30, 2022, September 30, 2022, December 31, 2022 and March 31, 2023, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.82 · Expires 2027-03-11 | Direct | 30,000 |
Reported balance
After 2022-03-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-11 · Grant · Acquired 30,000 · Balance 30,000 F2: The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The stock options are fully vested. F3: Not applicable. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The restricted stock units vest quarterly in equal increments on June 30, 2022, September 30, 2022, December 31, 2022 and March 31, 2023, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022.
F2: The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The stock options are fully vested.
F3: Not applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2022 Filed Apr 19, 2022 20:39 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Options (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $0.82 | Not disclosed |
DisclosureSEC source: 0001654954-22-005145 · section16.xml · derivative · entry 2 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-03-11 F2 · security: The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The stock options are fully vested. F3 · price: Not applicable. Read SEC document |
| March 11, 2022 Filed Apr 19, 2022 20:39 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-005145 · section16.xml · nonDerivative · entry 1 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The restricted stock units vest quarterly in equal increments on June 30, 2022, September 30, 2022, December 31, 2022 and March 31, 2023, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 11, 2022. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 01:00 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Option · Derivative | 30,000 | $0.00 Strike: $4.40 | $0.00 |
DisclosureSEC source: 0001654954-21-002825 · section16.xml · derivative · entry 5 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-03-11 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 01:00 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantRestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002825 · section16.xml · derivative · entry 4 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires 2022-03-12 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 01:00 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantRestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002825 · section16.xml · derivative · entry 3 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires 2021-12-31 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 01:00 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantRestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002825 · section16.xml · derivative · entry 2 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires 2021-09-30 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 01:00 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantRestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002825 · section16.xml · derivative · entry 1 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires 2021-06-30 Read SEC document |
| March 12, 2021 Filed Oct 5, 2021 17:42 UTC Amendment | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-010807 · section16.xml · nonDerivative · entry 1 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,000 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021. Read SEC document |
| May 27, 2020 Filed May 28, 2020 20:45 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Options · Derivative | 20,000 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001654954-20-006045 · section16.xml · derivative · entry 1 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-05-27 Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 13:19 UTC | cbdMD, Inc. YCBD · Entity 8230 | PurchaseCommon stock | 25,000 | $0.75 | $18,720.00 |
DisclosureSEC source: 0001654954-20-002414 · section16.xml · nonDerivative · entry 1 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 F1 · price: The price reported in column 4 is the weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.7396 to $0.7640, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 12:05 UTC | cbdMD, Inc. YCBD · Entity 8230 | PurchaseCommon Stock | 125,000 | $1.00 | $125,000.00 |
DisclosureSEC source: 0001654954-20-000511 · section16.xml · nonDerivative · entry 1 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Read SEC document |
| May 09, 2019 Filed May 13, 2019 16:21 UTC | cbdMD, Inc. LEVB · Entity 8230 | GrantStock Options · Derivative | 20,000 | $0.00 Strike: $5.41 | $0.00 |
DisclosureSEC source: 0001654954-19-005737 · section16.xml · derivative · entry 1 Ghiloni Peter J. · CIK 0001773696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-05-09 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.